Genetics and biology of vitamin D receptor polymorphisms.

Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev (2008) 5.28

Vitamin D Status and Rates of Cognitive Decline in a Multiethnic Cohort of Older Adults. JAMA Neurol (2015) 4.00

Race and Vitamin D Binding Protein Gene Polymorphisms Modify the Association of 25-Hydroxyvitamin D and Incident Heart Failure: The ARIC (Atherosclerosis Risk in Communities) Study. JACC Heart Fail (2015) 2.28

A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer. PLoS Med (2007) 2.20

Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk. Carcinogenesis (2009) 2.17

Vitamin D signaling, infectious diseases, and regulation of innate immunity. Infect Immun (2008) 1.77

The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer. Respir Res (2011) 1.65

Maternal serum 25-hydroxyvitamin D concentrations are associated with small-for-gestational age births in white women. J Nutr (2010) 1.64

Mendelian randomization: how it can--and cannot--help confirm causal relations between nutrition and cancer. Cancer Prev Res (Phila) (2009) 1.51

Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis. Am J Clin Nutr (2008) 1.49

The Association of Vitamin D Receptor Polymorphisms with Multiple Sclerosis in a Case-Control Study from Kuwait. PLoS One (2015) 1.43

Vitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels, and melanoma: UK case-control comparisons and a meta-analysis of published VDR data. Eur J Cancer (2009) 1.42

Evolution and function of the NR1I nuclear hormone receptor subfamily (VDR, PXR, and CAR) with respect to metabolism of xenobiotics and endogenous compounds. Curr Drug Metab (2006) 1.32

Vitamin D receptor gene as a candidate gene for Parkinson disease. Ann Hum Genet (2011) 1.22

Blood vitamin d levels in relation to genetic estimation of African ancestry. Cancer Epidemiol Biomarkers Prev (2010) 1.22

Genetics of disc degeneration. Eur Spine J (2006) 1.20

Association of vitamin D receptor gene polymorphism and Parkinson's disease in Koreans. J Korean Med Sci (2005) 1.18

Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk. Breast Cancer Res (2008) 1.15

Polymorphisms in the vitamin D receptor and risk of ovarian cancer in four studies. Cancer Res (2009) 1.15

Role of vitamin D in insulin resistance. J Biomed Biotechnol (2012) 1.11

Vitamin D and multiple sclerosis: epidemiology, immunology, and genetics. Curr Opin Neurol (2012) 1.09

Vitamin D receptor polymorphisms and breast cancer risk in a large population-based case-control study of Caucasian and African-American women. Breast Cancer Res (2007) 1.09

Vitamin D receptor polymorphisms and risk of epithelial ovarian cancer. Cancer Lett (2008) 1.09

Advances in predicting acute GVHD. Br J Haematol (2012) 1.07

Haplotype and genotypes of the VDR gene and cutaneous melanoma risk in non-Hispanic whites in Texas: a case-control study. Int J Cancer (2008) 1.06

Innate immune effectors in mycobacterial infection. Clin Dev Immunol (2011) 1.05

Association of vitamin D receptor gene variants, adiposity and colon cancer. Carcinogenesis (2008) 1.05

Vitamin D receptor polymorphisms in patients with cutaneous melanoma. Int J Cancer (2011) 1.04

Association Study between Idiopathic Scoliosis and Polymorphic Variants of VDR, IGF-1, and AMPD1 Genes. Genet Res Int (2015) 1.04

The Fok1 vitamin D receptor gene polymorphism is associated with plasma renin activity in Caucasians. Clin Endocrinol (Oxf) (2011) 1.03

Vitamin D receptor (VDR) polymorphisms and skin cancer: A systematic review. Dermatoendocrinol (2011) 1.02

5' regulatory and 3' untranslated region polymorphisms of vitamin D receptor gene in south Indian HIV and HIV-TB patients. J Clin Immunol (2008) 1.02

The effects of age, sex, ethnicity, and spinal level on the rate of intervertebral disc degeneration: a review of 1712 intervertebral discs. Spine (Phila Pa 1976) (2011) 1.00

Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis. Mult Scler (2009) 0.99

A novel SNP in a vitamin D response element of the CYP24A1 promoter reduces protein binding, transactivation, and gene expression. J Steroid Biochem Mol Biol (2008) 0.99

Vitamin D receptor gene and aggrecan gene polymorphisms and the risk of intervertebral disc degeneration - a meta-analysis. PLoS One (2012) 0.98

Plasma 1,25 dihydroxy vitamin D3 level and expression of vitamin d receptor and cathelicidin in pulmonary tuberculosis. J Clin Immunol (2009) 0.98

Vitamin D receptor gene polymorphisms and prognosis of breast cancer among African-American and Hispanic women. PLoS One (2013) 0.98

The osteogenic transcription factor runx2 controls genes involved in sterol/steroid metabolism, including CYP11A1 in osteoblasts. Mol Endocrinol (2009) 0.95

Vitamin D receptor rs2228570 polymorphism and invasive ovarian carcinoma risk: pooled analysis in five studies within the Ovarian Cancer Association Consortium. Int J Cancer (2011) 0.95

Vitamin D receptor gene polymorphisms are associated with adiposity phenotypes. Am J Clin Nutr (2010) 0.95

Maternal vitamin D receptor genetic variation contributes to infant birthweight among black mothers. Am J Med Genet A (2011) 0.95

Regulatory role of promoter and 3' UTR variants of vitamin D receptor gene on cytokine response in pulmonary tuberculosis. J Clin Immunol (2008) 0.94

Vitamin D receptor polymorphisms (FokI, BsmI) and breast cancer risk: association replication in two case-control studies within French Canadian population. Endocr Relat Cancer (2008) 0.94

Vitamin D deficiency in girls from South Brazil: a cross-sectional study on prevalence and association with vitamin D receptor gene variants. BMC Pediatr (2012) 0.94

High latitude and marine diet: vitamin D status in elderly Faroese. Br J Nutr (2010) 0.94

Pathway-Targeted Pharmacogenomics of CYP1A2 in Human Liver. Front Pharmacol (2010) 0.93

25-hydroxyvitamin D deficiency, exacerbation frequency and human rhinovirus exacerbations in chronic obstructive pulmonary disease. BMC Pulm Med (2012) 0.93

Vitamin D receptor gene haplotypes and polymorphisms and risk of breast cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev (2012) 0.93

Vitamin D Receptor Gene Expression and Function in a South African Population: Ethnicity, Vitamin D and FokI. PLoS One (2013) 0.93

Association between vitamin D receptor gene polymorphisms and breast cancer risk: a meta-analysis of 39 studies. PLoS One (2014) 0.92

Interaction of vitamin D receptor with HLA DRB1 0301 in type 1 diabetes patients from North India. PLoS One (2009) 0.92

FokI polymorphism in the vitamin D receptor gene (VDR) and its association with lumbar spine pathologies in the Italian population: a case-control study. PLoS One (2014) 0.92

Vitamin D receptor gene polymorphisms and hepatocellular carcinoma in alcoholic cirrhosis. World J Gastroenterol (2010) 0.91

Vitamin D receptor gene polymorphisms in patients with urolithiasis. Urol Res (2006) 0.91

Both 25-hydroxyvitamin-D3 and 1,25-dihydroxyvitamin-D3 reduces inflammatory response in human periodontal ligament cells. PLoS One (2014) 0.91

Vitamin D receptor gene polymorphisms are associated with obesity and inflammosome activity. PLoS One (2014) 0.91

Induction of triggering receptor expressed on myeloid cells (TREM-1) in airway epithelial cells by 1,25(OH)₂ vitamin D₃. Innate Immun (2011) 0.90

Vitamin D receptor gene BsmI, FokI, ApaI and TaqI polymorphisms and the risk of systemic lupus erythematosus. Mol Biol Rep (2012) 0.90

Race, vitamin D-binding protein gene polymorphisms, 25-hydroxyvitamin D, and incident diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr (2015) 0.90

Polymorphisms in the vitamin D receptor gene are associated with muscle strength in men and women. Osteoporos Int (2007) 0.90

Vitamin D insufficiency in Arabs and South Asians positively associates with polymorphisms in GC and CYP2R1 genes. PLoS One (2014) 0.90

Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with peak bone mass in non-sedentary men: results from the Odense androgen study. Calcif Tissue Int (2007) 0.90

Investigation of the vitamin D receptor gene (VDR) and its interaction with protein tyrosine phosphatase, non-receptor type 2 gene (PTPN2) on risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY). J Steroid Biochem Mol Biol (2012) 0.89

Impact of vitamin D on infectious disease. Am J Med Sci (2015) 0.89

Circulating 25-hydroxyvitamin-D and risk of colorectal adenomas and hyperplastic polyps. Nutr Cancer (2011) 0.89

Intestinal CYP3A4 and midazolam disposition in vivo associate with VDR polymorphisms and show seasonal variation. Biochem Pharmacol (2012) 0.88

Vitamin D3 receptor is highly expressed in Hodgkin's lymphoma. BMC Cancer (2012) 0.88

Prognostic significance of vitamin D receptor polymorphisms in head and neck squamous cell carcinoma. PLoS One (2011) 0.88

Vitamin D receptor polymorphisms and renal cancer risk in Central and Eastern Europe. J Toxicol Environ Health A (2008) 0.88

Calcium and vitamin D in sarcoidosis: how to assess and manage. Semin Respir Crit Care Med (2010) 0.87

Thyroid cancer resistance to vitamin D receptor activation is associated with 24-hydroxylase levels but not the ff FokI polymorphism. Thyroid (2010) 0.87

Vitamin d, sunlight and prostate cancer risk. Adv Prev Med (2011) 0.87

Vitamin D receptor gene polymorphisms on the risk of tuberculosis, a meta-analysis of 29 case-control studies. PLoS One (2013) 0.87

Association of vitamin D receptor gene polymorphisms with asthma risk: systematic review and updated meta-analysis of case-control studies. Lung (2014) 0.87

Vitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk. Cancer Causes Control (2014) 0.86

Association of vitamin D receptor BsmI gene polymorphism with risk of tuberculosis: a meta-analysis of 15 studies. PLoS One (2013) 0.86

Polymorphisms in the vitamin D Receptor (VDR) and the risk of ovarian cancer: a meta-analysis. PLoS One (2013) 0.86

Association between vitamin D receptor polymorphisms and multiple sclerosis: systematic review and meta-analysis of case-control studies. Cell Mol Immunol (2014) 0.86

Nutrigenomics, vitamin D and cancer prevention. J Nutrigenet Nutrigenomics (2011) 0.86

The renin-angiotensin-aldosterone system and calcium-regulatory hormones. J Hum Hypertens (2015) 0.85

Genetic polymorphisms of interleukin-1 alpha and the vitamin d receptor in mexican mestizo patients with intervertebral disc degeneration. Int J Genomics (2014) 0.85

Vitamin D receptor (VDR) polymorphisms and risk of ovarian cancer in Caucasian and African American women. Gynecol Oncol (2012) 0.85

Immunomodulation by vitamin D: implications for TB. Expert Rev Clin Pharmacol (2011) 0.85

Metabolic syndrome and nephrolithiasis: can we hypotize a common background? Clin Cases Miner Bone Metab (2008) 0.84

Association between Vitamin D Receptor Gene BsmI Polymorphism and Bone Mineral Density in A Population of 146 Iranian Women. Cell J (2013) 0.84

Association between vitamin D receptor polymorphisms and haplotypes with pulmonary tuberculosis. Biomed Rep (2014) 0.84

An exploratory analysis of common genetic variants in the vitamin D pathway including genome-wide associated variants in relation to glioma risk and outcome. Cancer Causes Control (2012) 0.84

Vitamin d: are we ready to supplement for breast cancer prevention and treatment? ISRN Oncol (2013) 0.83

Vitamin D and polymorphisms of VDR gene in patients with systemic lupus erythematosus. Clin Rheumatol (2012) 0.83

Top Three Pharmacogenomics and Personalized Medicine Applications at the Nexus of Renal Pathophysiology and Cardiovascular Medicine. Curr Pharmacogenomics Person Med (2011) 0.83

The role of vitamin d deficiency in the incidence, progression, and complications of type 1 diabetes mellitus. Int J Endocrinol (2013) 0.83

Gender differences in the VDR-FokI polymorphism and conventional non-genetic risk factors in association with lumbar spine pathologies in an Italian case-control study. Int J Mol Sci (2015) 0.83

High-dose vitamin D3 reduces deficiency caused by low UVB exposure and limits HIV-1 replication in urban Southern Africans. Proc Natl Acad Sci U S A (2015) 0.82

Very important pharmacogene summary for VDR. Pharmacogenet Genomics (2012) 0.82

Interactions between serum vitamin D levels and vitamin D receptor gene FokI polymorphisms for renal function in patients with type 2 diabetes. PLoS One (2012) 0.82

Plasma Vitamin D Levels And Vitamin D Receptor Polymorphisms Are Associated with Survival of Non-small Cell Lung Cancer. Chin J Cancer Res (2011) 0.82

Vitamin-D receptor (VDR) gene polymorphisms (Taq-I & Apa-I) in Syrian healthy population. Meta Gene (2014) 0.82

Vitamin D receptor gene BsmI and FokI polymorphisms in relation to ovarian cancer risk in the Polish population. Genet Test Mol Biomarkers (2013) 0.81

Vitamin D, folate, and potential early lifecycle environmental origin of significant adult phenotypes. Evol Med Public Health (2014) 0.81

Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet (2012) 5.48

Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat Genet (2009) 5.32

Meta-analysis of genome-wide scans for human adult stature identifies novel Loci and associations with measures of skeletal frame size. PLoS Genet (2009) 4.24

Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med (2004) 3.32

Estrogen receptor alpha gene polymorphisms and risk of myocardial infarction. JAMA (2004) 2.93

A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res (2004) 2.92

Collaborative meta-analysis: associations of 150 candidate genes with osteoporosis and osteoporotic fracture. Ann Intern Med (2009) 2.80

Association between genetic variation in the gene for insulin-like growth factor-I and low birthweight. Lancet (2002) 2.78

Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study. J Clin Endocrinol Metab (2002) 2.76

The association between common vitamin D receptor gene variations and osteoporosis: a participant-level meta-analysis. Ann Intern Med (2006) 2.74

C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study. J Clin Oncol (2006) 2.74

Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis. JAMA (2008) 2.52

An integration of genome-wide association study and gene expression profiling to prioritize the discovery of novel susceptibility Loci for osteoporosis-related traits. PLoS Genet (2010) 2.43

Thiazide diuretics and the risk for hip fracture. Ann Intern Med (2003) 2.24

Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes. JAMA (2004) 2.20

Selective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fractures. J Clin Psychopharmacol (2008) 2.12

A genome-wide association study identifies an osteoarthritis susceptibility locus on chromosome 7q22. Arthritis Rheum (2010) 2.02

Promoter and 3'-untranslated-region haplotypes in the vitamin d receptor gene predispose to osteoporotic fracture: the rotterdam study. Am J Hum Genet (2005) 1.97

A functional polymorphism in the catechol-O-methyltransferase gene is associated with osteoarthritis-related pain. Arthritis Rheum (2009) 1.94

Association of the ER22/23EK polymorphism in the glucocorticoid receptor gene with survival and C-reactive protein levels in elderly men. Am J Med (2004) 1.93

Identification of the BclI polymorphism in the glucocorticoid receptor gene: association with sensitivity to glucocorticoids in vivo and body mass index. Clin Endocrinol (Oxf) (2003) 1.83

Mild hyponatremia as a risk factor for fractures: the Rotterdam Study. J Bone Miner Res (2011) 1.77

Loci at chromosomes 13, 19 and 20 influence age at natural menopause. Nat Genet (2009) 1.72

Large-scale evidence for the effect of the COLIA1 Sp1 polymorphism on osteoporosis outcomes: the GENOMOS study. PLoS Med (2006) 1.68

Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial. J Clin Endocrinol Metab (2002) 1.59

The incidence of vertebral fractures in men and women: the Rotterdam Study. J Bone Miner Res (2002) 1.57

Association of 5' estrogen receptor alpha gene polymorphisms with bone mineral density, vertebral bone area and fracture risk. Hum Mol Genet (2003) 1.56

A polymorphism in the glucocorticoid receptor gene, which decreases sensitivity to glucocorticoids in vivo, is associated with low insulin and cholesterol levels. Diabetes (2002) 1.55

Smoking-dependent effects of the angiotensin-converting enzyme gene insertion/deletion polymorphism on blood pressure. J Hypertens (2004) 1.48

SIRT1 genetic variation is related to BMI and risk of obesity. Diabetes (2009) 1.44

Effect of monitoring bone turnover markers on persistence with risedronate treatment of postmenopausal osteoporosis. J Clin Endocrinol Metab (2007) 1.43

Vitamin D status, bone mineral density, and the development of radiographic osteoarthritis of the knee: The Rotterdam Study. J Clin Rheumatol (2009) 1.42

Common genetic variation of the low-density lipoprotein receptor-related protein 5 and 6 genes determines fracture risk in elderly white men. J Bone Miner Res (2005) 1.37

Vitamin D receptor gene polymorphisms in relation to Vitamin D related disease states. J Steroid Biochem Mol Biol (2004) 1.36

Genotypic and phenotypic characteristics of Dutch patients with early onset Parkinson's disease. Mov Disord (2009) 1.36

Estrogen receptor alpha gene haplotype is associated with radiographic osteoarthritis of the knee in elderly men and women. Arthritis Rheum (2003) 1.34

The activin A-follistatin system: potent regulator of human extracellular matrix mineralization. FASEB J (2007) 1.31

Use of statins and fracture: results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials. Arch Intern Med (2004) 1.29

Risk factors for incident vertebral fractures in men and women: the Rotterdam Study. J Bone Miner Res (2004) 1.27

Polymorphisms in the sclerosteosis/van Buchem disease gene (SOST) region are associated with bone-mineral density in elderly whites. Am J Hum Genet (2004) 1.26

Effects of serum TSH and FT4 levels and the TSHR-Asp727Glu polymorphism on bone: the Rotterdam Study. Clin Endocrinol (Oxf) (2007) 1.25

Anti-Müllerian hormone and anti-Müllerian hormone type II receptor polymorphisms are associated with follicular phase estradiol levels in normo-ovulatory women. Hum Reprod (2007) 1.23

Results of the proximal femoral nail anti-rotation (PFNA) in elderly Chinese patients. Int Orthop (2009) 1.23

Endogenous sex hormones, sex hormone-binding globulin, and the risk of incident vertebral fractures in elderly men and women: the Rotterdam Study. J Clin Endocrinol Metab (2004) 1.23

The epithelial Ca2+ channel TRPV5 is essential for proper osteoclastic bone resorption. Proc Natl Acad Sci U S A (2005) 1.23

Heritabilities, apolipoprotein E, and effects of inbreeding on plasma lipids in a genetically isolated population: the Erasmus Rucphen Family Study. Eur J Epidemiol (2007) 1.20

Bone mineral density and the risk of breast cancer: the Rotterdam Study. Bone (2003) 1.20

High bone mineral density and fracture risk in type 2 diabetes as skeletal complications of inadequate glucose control: the Rotterdam Study. Diabetes Care (2013) 1.19

Cdx-2 polymorphism in the promoter region of the human vitamin D receptor gene determines susceptibility to fracture in the elderly. J Bone Miner Res (2003) 1.18

Molecular tectonics: self-complementary supramolecular Se...N synthons directing assembly of 1D silver chains into 3D porous molecular architectures. Inorg Chem (2005) 1.14

A polymorphism in the AMH type II receptor gene is associated with age at menopause in interaction with parity. Hum Reprod (2007) 1.12

TGF-beta 1 polymorphisms and risk of myocardial infarction and stroke: the Rotterdam Study. Stroke (2006) 1.11

Estrogen receptor beta (ESR2) polymorphisms in interaction with estrogen receptor alpha (ESR1) and insulin-like growth factor I (IGF1) variants influence the risk of fracture in postmenopausal women. J Bone Miner Res (2006) 1.10

A polymorphism in the IGF-I gene influences the age-related decline in circulating total IGF-I levels. Eur J Endocrinol (2003) 1.10

Vitamin D receptor gene haplotype is associated with body height and bone size. J Clin Endocrinol Metab (2007) 1.10

Estrogen receptor alpha gene polymorphisms are associated with estradiol levels in postmenopausal women. Eur J Endocrinol (2005) 1.09

The influence of an insulin-like growth factor I gene promoter polymorphism on hip bone geometry and the risk of nonvertebral fracture in the elderly: the Rotterdam Study. J Bone Miner Res (2004) 1.08

Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: the GENOMOS study. Bone (2007) 1.07

The new proximal femoral nail antirotation-Asia: early results. Orthopedics (2011) 1.07

Vitamin D binding protein genotype and osteoporosis. Calcif Tissue Int (2009) 1.07

Glucocorticoid receptor polymorphism affects transrepression but not transactivation. J Clin Endocrinol Metab (2006) 1.07

The role of body mass index, insulin, and adiponectin in the relation between fat distribution and bone mineral density. Calcif Tissue Int (2009) 1.04

Osteoarthritis of the knee is associated with vertebral and nonvertebral fractures in the elderly: the Rotterdam Study. Arthritis Rheum (2003) 1.02

Estrogen receptor alpha gene variation is associated with risk of myocardial infarction in more than seven thousand men from five cohorts. Circ Res (2006) 1.01

Endogenous estradiol and risk of dementia in women and men: the Rotterdam Study. Ann Neurol (2003) 1.00

Height in pre- and postmenopausal women is influenced by estrogen receptor alpha gene polymorphisms. J Clin Endocrinol Metab (2004) 0.99

HMG-CoA reductase inhibitors and the risk of vertebral fracture. J Bone Miner Res (2004) 0.98

SIRT1 genetic variation and mortality in type 2 diabetes: interaction with smoking and dietary niacin. Free Radic Biol Med (2009) 0.97

The cause of the fragile relationship between the Pacific El Niño and the Atlantic Niño. Nature (2006) 0.97

Endogenous oestrogens are related to cognition in healthy elderly women. Clin Endocrinol (Oxf) (2005) 0.97

miR-145 sensitizes ovarian cancer cells to paclitaxel by targeting Sp1 and Cdk6. Int J Cancer (2014) 0.96

miR-449a Regulates proliferation and chemosensitivity to cisplatin by targeting cyclin D1 and BCL2 in SGC7901 cells. Dig Dis Sci (2013) 0.95

Evidence that the mitochondrial leucyl tRNA synthetase (LARS2) gene represents a novel type 2 diabetes susceptibility gene. Diabetes (2005) 0.95

A common polymorphism renders the luteinizing hormone receptor protein more active by improving signal peptide function and predicts adverse outcome in breast cancer patients. J Clin Endocrinol Metab (2006) 0.95

Osteoporosis in men and women: a story about bone mineral density thresholds and hip fracture risk. J Bone Miner Res (2002) 0.95

Serum insulin-like growth factor binding protein-2 levels as an indicator of functional ability in elderly men. Eur J Endocrinol (2003) 0.95

The catechol-O-methyltransferase Met158 low-activity allele and association with nonvertebral fracture risk in elderly men. J Clin Endocrinol Metab (2007) 0.94

Withdrawal of fall-risk-increasing drugs in older persons: effect on tilt-table test outcomes. J Am Geriatr Soc (2007) 0.93

A common polymorphism in the CYP3A7 gene is associated with a nearly 50% reduction in serum dehydroepiandrosterone sulfate levels. J Clin Endocrinol Metab (2005) 0.93

Inappropriate benzodiazepine use in older adults and the risk of fracture. Br J Clin Pharmacol (2008) 0.93

Arterial stiffness in postmenopausal women: determinants of pulse wave velocity. J Hypertens (2002) 0.92

An igf-I gene polymorphism modifies the risk of diabetic retinopathy. Diabetes (2006) 0.92

Berberine Sensitizes Human Ovarian Cancer Cells to Cisplatin Through miR-93/PTEN/Akt Signaling Pathway. Cell Physiol Biochem (2015) 0.91

The importance of oestrogens in males. Clin Endocrinol (Oxf) (2003) 0.91

A population-based study of the effect of the HFE C282Y and H63D mutations on iron metabolism. Eur J Hum Genet (2003) 0.90

Evidence of epistasis between the catechol-O-methyltransferase and aldehyde dehydrogenase 3B1 genes in paranoid schizophrenia. Biol Psychiatry (2009) 0.89

Higher estrogen levels are not associated with larger hippocampi and better memory performance. Arch Neurol (2003) 0.89

Reduced prefrontal activation during Tower of London in first-episode schizophrenia: a multi-channel near-infrared spectroscopy study. Neurosci Lett (2010) 0.89

Tetrandrine induces mitochondria-mediated apoptosis in human gastric cancer BGC-823 cells. PLoS One (2013) 0.89

Comparison of low, multidirectional locked nailing and plating in the treatment of distal tibial metadiaphyseal fractures. Int Orthop (2012) 0.89

Association between an insulin-like growth factor I gene promoter polymorphism and bone mineral density in the elderly: the Rotterdam Study. J Clin Endocrinol Metab (2003) 0.89

The cell surface protein gene ecm33+ is a target of the two transcription factors Atf1 and Mbx1 and negatively regulates Pmk1 MAPK cell integrity signaling in fission yeast. Mol Biol Cell (2009) 0.89

Genome-wide association study for radiographic vertebral fractures: a potential role for the 16q24 BMD locus. Bone (2014) 0.88